543 related articles for article (PubMed ID: 16078212)
21. [Neuroblastoma in children under than 1 year of age].
Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of abdominal neuroblastoma in Essen].
Lange R; Kremens B; Grigoleit U; Erhard J
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1073-7. PubMed ID: 9101784
[TBL] [Abstract][Full Text] [Related]
23. [DNA-ploidy and proliferation in metastatic neuroblastoma].
Böhm N; Lampert F
Klin Padiatr; 1982; 194(4):270-4. PubMed ID: 7132228
[TBL] [Abstract][Full Text] [Related]
24. [Peripheral neurogenic tumors--surgical therapy of neuroblastoma. Review and personal results].
Prokop A; Pichlmaier H; Berthold F
Zentralbl Chir; 1993; 118(6):315-21. PubMed ID: 8342338
[TBL] [Abstract][Full Text] [Related]
25. [MR imaging in patients with bone marrow metastases of neuroblastoma].
Kanegawa K; Nishiyama S; Koshino T; Mabuchi O; Muraji T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):368-72. PubMed ID: 8710458
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
27. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
28. Metastatic neuroblastoma to the mandible in a 3-year-old boy: a case report.
Otmani N; Khattab M
Med Oral Patol Oral Cir Bucal; 2007 May; 12(3):E201-4. PubMed ID: 17468714
[TBL] [Abstract][Full Text] [Related]
29. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
31. [Neuroblastoma in children. Clinical staging and management (author's transl)].
Haas RJ; Lampert F; Janka G; Helmig M; Holschneider AM; Hecker WC
Klin Padiatr; 1979 Jul; 191(4):347-55. PubMed ID: 381767
[TBL] [Abstract][Full Text] [Related]
32. Proposal and assessment of Japanese tumor node metastasis postsurgical histopathological staging system for neuroblastoma based on an analysis of 495 cases.
Nakagawara A; Morita K; Okabe I; Uchino J; Ohi R; Iwafuchi M; Matsuyama S; Nagashima K; Takahashi H; Nakajo T
Jpn J Clin Oncol; 1991 Feb; 21(1):1-7. PubMed ID: 2067117
[TBL] [Abstract][Full Text] [Related]
33. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
[TBL] [Abstract][Full Text] [Related]
34. [Malignant bone marrow infiltration in nuclear magnetic resonance tomography].
Gamillscheg A; Urban C; Ranner G; Kaulfersch W; Lackner H; Hauer C; Slavc I; Schmid G
Padiatr Padol; 1989; 24(2):103-11. PubMed ID: 2761997
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system relapse following bone marrow transplantation in stage IV neuroblastoma.
Palasis S; Morris J; Egelhoff JC
Pediatr Hematol Oncol; 1999; 16(5):443-52. PubMed ID: 10505321
[TBL] [Abstract][Full Text] [Related]
36. Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma.
Cheung IY; Feng Y; Cheung NK
Pediatr Blood Cancer; 2013 Jul; 60(7):E32-4. PubMed ID: 23335404
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of neuroblastoma by electron microscopy of bone marrow aspirates.
Mackay B; Masse SR; King OY; Butler J
Pediatrics; 1975 Dec; 56(6):1045-9. PubMed ID: 1196755
[TBL] [Abstract][Full Text] [Related]
38. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
[TBL] [Abstract][Full Text] [Related]
40. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
